Podnos Yale
SEC CIK 1891104 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| STLN | Starling Oncology, Inc. | Chief Medical Off | 265.0K | $9,418 | $276.8K | 24 | 2021-11-12 | 2026-07-14 |
Most active insiders at STLN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Chernett Jorey | 10% | $2.69M | — |
| 2 | Hively Brad | Dir | — | $2.00M |
| 3 | Kaushal Mohit | Dir | — | $335.1K |
| 4 | Podnos Yale | Chief Medical Off | — | $276.4K |
| 5 | Pacala Mark L | Dir | — | $200.0K |
| 6 | Carter Robert Ross | CFO | — | $879.32 |
| 7 | England Kristin | Chief Administrative Off | — | — |
| 8 | Langsam Jeffrey | Chief Clinical Off | — | — |
| 9 | Ling Gabriel | Dir | — | — |
| 10 | TOI M, LLC | Dir | — | — |
Transactions 24
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-07-16 20:05 | 2026-07-14 | STLN | Starling Oncology, Inc. | Podnos Yale | Chief Medical Off | M - OptEx | $1.90 | +23.5K | 265.0K | +10% | +$44.6K |
| DMT | 2026-07-16 20:05 | 2026-07-14 | STLN | Starling Oncology, Inc. | Podnos Yale | Chief Medical Off | S - Sale+OE | $6.41 | -23.5K | 259.5K | -8% | -$150.3K |
| T | 2026-06-09 19:06 | 2026-06-08 | STLN | Starling Oncology, Inc. | Podnos Yale | Chief Medical Off | S - Sale | $5.38 | -23.5K | 259.5K | -8% | -$126.1K |
| 2026-05-22 17:39 | 2026-05-21 | STLN | Starling Oncology, Inc. | Podnos Yale | Chief Medical Off | J - Other | $4.47 | -1,805 | 283.0K | -0.6% | -$8,068 | |
| 2026-04-01 20:51 | 2026-03-27 | STLN | Starling Oncology, Inc. | Podnos Yale | Chief Medical Off | A - Grant | $0.00 | +66.4K | 301.0K | +28% | $0 | |
| 2026-04-01 20:51 | 2026-03-27 | STLN | Starling Oncology, Inc. | Podnos Yale | Chief Medical Off | J - Other | $3.07 | -16.2K | 284.8K | -5% | -$49.7K | |
| 2026-03-18 | 2026-03-17 | STLN | Starling Oncology, Inc. | Podnos Yale | Chief Medical Off | J - Other | $3.59 | -3,420 | 234.5K | -1% | -$12.3K | |
| 2025-11-19 | 2025-11-17 | STLN | Starling Oncology, Inc. | Podnos Yale | Chief Medical Off | A - Grant | $0.00 | +2,086 | 237.9K | +0.9% | $0 | |
| M | 2025-11-14 | 2025-11-12 | STLN | Starling Oncology, Inc. | Podnos Yale | Chief Medical Off | A - Grant | $0.00 | +1,508 | 235.8K | +0.6% | $0 |
| 2025-05-22 | 2025-05-21 | STLN | Starling Oncology, Inc. | Podnos Yale | Chief Medical Off | D - Sale to Iss | $2.68 | -1,801 | 234.3K | -0.8% | -$4,827 | |
| 2025-04-02 | 2025-03-31 | STLN | Starling Oncology, Inc. | Podnos Yale | Chief Medical Off | A - Grant | $0.00 | +157.1K | 236.1K | +199% | $0 | |
| D | 2025-03-28 | 2025-03-26 | STLN | Starling Oncology, Inc. | Podnos Yale | Chief Medical Off | P - Purchase | $1.04 | +9,056 | 79.0K | +13% | +$9,418 |
| 2025-03-20 | 2025-03-19 | STLN | Starling Oncology, Inc. | Podnos Yale | Chief Medical Off | D - Sale to Iss | $0.89 | -2,975 | 70.0K | -4% | -$2,648 | |
| M | 2024-11-21 | 2024-11-20 | STLN | Starling Oncology, Inc. | Podnos Yale | Chief Medical Off | D - Sale to Iss | $0.14 | -3,002 | 74.0K | -4% | -$420.28 |
| M | 2024-11-18 | 2024-11-12 | STLN | Starling Oncology, Inc. | Podnos Yale | Chief Medical Off | J - Other | $0.00 | -28.4K | 76.0K | -27% | $0 |
| D | 2024-05-23 | 2024-05-21 | STLN | Starling Oncology, Inc. | Podnos Yale | Chief Medical Off | A - Grant | $0.00 | +17.5K | 104.4K | +20% | $0 |
| 2023-11-22 | 2023-11-21 | STLN | Starling Oncology, Inc. | Podnos Yale | Chief Medical Off | D - Sale to Iss | $2.19 | -1,530 | 86.8K | -2% | -$3,351 | |
| M | 2023-11-16 | 2023-11-14 | STLN | Starling Oncology, Inc. | Podnos Yale | Chief Medical Off | D - Sale to Iss | $2.39 | -2,098 | 88.4K | -2% | -$5,014 |
| D | 2023-03-21 | 2023-03-17 | STLN | Starling Oncology, Inc. | Podnos Yale | Chief Medical Off | A - Grant | $0.00 | +33.2K | 90.5K | +58% | $0 |
| A | 2022-11-22 | 2022-11-15 | STLN | Starling Oncology, Inc. | Podnos Yale | Chief Medical Off | S - Sale | $2.03 | -199 | 43.1K | -0.5% | -$403.97 |
| D | 2022-11-21 | 2022-11-17 | STLN | Starling Oncology, Inc. | Podnos Yale | Chief Medical Off | A - Grant | $0.00 | +14.2K | 57.2K | +33% | $0 |
| 2022-11-17 | 2022-11-15 | STLN | Starling Oncology, Inc. | Podnos Yale | Chief Medical Off | D - Sale to Iss | $2.03 | -199 | 43.1K | -0.5% | -$403.97 | |
| DM | 2022-03-23 | 2022-03-21 | STLN | Starling Oncology, Inc. | Podnos Yale | Chief Medical Off | A - Grant | $0.00 | +14.9K | 43.3K | +52% | $0 |
| DM | 2021-11-16 | 2021-11-12 | STLN | Starling Oncology, Inc. | Podnos Yale | Chief Medical Off | A - Grant | $0.00 | +28.4K | 11.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations